VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 11/12/2021
** VAERS DATABASE Last updated: November 12, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer
199,106MODERNA
36,710JANSSEN
5,381PFIZER\BIONTECH
2,555GLAXOSMITHKLINE BIOLOGICALS
1,469UNKNOWN MANUFACTURER
897MERCK & CO. INC.
627SEQIRUS, INC.
112DYNAVAX TECHNOLOGIES CORPORATION
91SANOFI PASTEUR
75NOVARTIS VACCINES AND DIAGNOSTICS
40EMERGENT BIOSOLUTIONS
14PAXVAX
12TEVA PHARMACEUTICALS
12PROTEIN SCIENCES CORPORATION
9PFIZER\WYETH
4BERNA BIOTECH, LTD.
4SMITHKLINE BEECHAM
3INTERCELL AG
1MEDIMMUNE VACCINES, INC.
1CSL LIMITED

COVID19 Lot Number

VAX LOT Total
2S9CL7,949
7,473
2,547
1,506
1,187
1,051
1,049
s0294561,043
866
IMM209861
816
UT7065MA766
657
579
U62828AA563
557
538
U6737AA516
515
S034636506
4F472471
458
P100253275449
444
276563436
429
418
4BH32414
MENVEO404
PP9L5362
UJ446AA337
319
306
290
271
49TM3270
R1B252M253
4F472179
933622147
C5763AA144
CW3116134
3Y7NL126
UNK114
113
ARBA141A105
104
103
96
300057A90
79
1F4EB73
R1B743M62
56
UJ090AA55
51
UH894AB46
45
UNK44
UNK42
42
EJ168638
Unknown36
35
34
32
32
26
el128424
24
A115A22
22
EN620222
21
UNK20
20
19
Z127A19
19
17
JEV18K95E15
12
111798PI12
10
A739088
No batch number8
3333324181078
6
6
TAR356
5
5
U6935AA5
UNK5
4
unknown4
3
2
55RB72
2
2
2
2
2
U7124AA2
JEV18A68E2
2
ABYB05BA1
1
1
1
1
AMVA436A1
1
1
TJ3521
A130A; VIS give1
1
U7140BB1
1
1
SP UP016AA1
1
1808P08802/ESV01
037K20A300,947
EL1284288,578
57,766
1,432

Incidents per State

State Total
82,750
CA62,821
FL38,209
TX36,512
NY34,921
PA23,646
IN23,622
IL20,597
MI19,590
OH19,426
NJ18,413
NC16,769
GA15,932
WA15,351
VA15,234
MA14,876
AZ14,206
MN12,940
MD12,656
CO11,908
WI11,425
MO10,240
TN9,685
OR8,768
KY8,437
CT8,300
SC6,700
OK6,293
AL5,692
LA5,025
IA4,825
KS4,821
UT4,637
NV4,374
NM3,967
AR3,807
ME3,161
NH3,096
NE2,918
MS2,859
ID2,785
WV2,469
HI2,459
PR2,417
MT2,414
RI2,076
DE1,868
AK1,830
VT1,734
DC1,715
ND1,388
SD1,269
WY866
GU118
VI69
AS47
MP29
MH8
XB6
FM4
QM3
XV2
XL1

ID: 1652282
Sex: F
Age:
State: OH

Vax Date: 05/12/2021
Onset Date: 05/21/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: Kidneys - hives bruising difficult urinating; Kidneys - hives bruising difficult urinating; Kidneys - hives bruising difficult urinating, back pain; Kidneys - hives bruising difficult urinating; back pain; Kidneys - hives bruising difficult urinating; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old [non-pregnant] adult female received the second dose of intramuscular BNT162B2 (solution for injection, Lot ER8736 expiry information not provided) as a single dose in the left arm on 12May2021 at 11:30 (at 54-years-old) for COVID-19 immunization. There was no medical history reported. Concomitant medications included lamotrigine (LAMICTAL); paroxetine hydrochloride (PAXIL), vitamin B NOS, and vaccinium macrocarpon (CRANBERRY). The patient denied receiving any other vaccine within four weeks of this vaccine. The patient denied any diagnosis of COVID prior to receiving the vaccine and the patient was not pregnant at the time of vaccine. The patient denied being tested for COVID-19 since receiving the vaccine. The patient previously received COVID-19 immunization with the first dose of intramuscular BNT162B2 (solution for injection, Lot ER8729 expiry information not provided) as a single dose in the left arm on 21Apr2021 at 11:30 (at 54-years-old). The patient reported that on 21May2021 at 08:30 she experienced Kidneys - hives bruising difficult urinating, and back pain; which resulted in a visit to a doctor or other healthcare professional office. Treatment for the events included unspecified medications. The outcome of the events Kidneys - hives bruising difficult urinating, and back pain was unknown.

Other Meds: LAMICTAL; PAXIL [PAROXETINE HYDROCHLORIDE]; VITAMIN B NOS; CRANBERRY

Current Illness:

ID: 1652283
Sex: M
Age:
State: TN

Vax Date: 04/16/2021
Onset Date: 05/21/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025L20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: Shingles on forearm; rash on other side of forearm and upper arm area; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN 6205) via an unspecified route of administration on 16Apr2021 at 12:00 (at the age of 31-year-old) as a single dose for COVID-19 immunisation. Medical history included that the patient was allergic to sunblock. Concomitant medications included Allopurinol (MANUFACTURER UNKNOWN) from an unknown date and unknown if ongoing for an unknown indication. The patient also received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration on 25Mar2021 (at the age of 31-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 21May2021 the patient experienced shingles on forearm and rash on other side of forearm and upper arm area. Therapeutic measures were not taken as a result of the events shingles on forearm and rash on other side of forearm and upper arm area. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events shingles on forearm and rash on other side of forearm and upper arm area was not resolved. No follow-up attempts are needed. No further information is expected.

Other Meds: ALLOPURINOL

Current Illness:

ID: 1652284
Sex: M
Age:
State: DE

Vax Date: 02/11/2021
Onset Date: 03/16/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EL1284
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: Red spots on front and back of my body and some on both legs; extreme itching, hundred of itchy spots; This is a spontaneous report from a contactable consumer, the patient. A 71-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN9263) via an unspecified route of administration in the left arm on 11Feb2021 (at the age of 71-years-old) as a single dose for COVID-19 immunisation. Medical history included diabetes, sarcoid and rheumatoid arthritis (RA). Concomitant medications included omeprazole (MANUFACTURER UNKNOWN), metformin (MANUFACTURER UNKNOWN), lisinopril (MANUFACTURER UNKNOWN) and tamsulosin (MANUFACTURER UNKNOWN). The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9263) via an unspecified route of administration in the left arm on 21Jan2021 as a single dose for COVID-19 immunisation. The patient also previously received niacin (MANUFACTURER UNKNOWN), methotrexate (MANUFACTURER UNKNOWN) and rosuvastatin (MANUFACTURER UNKNOWN) and developed allergy to all the drugs. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 16Mar2021, the patient experienced red spots on front and back of his body and some on both legs, extreme itching and hundreds of itchy spots. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of events and included treatment with prednisolone and photo therapy. The clinical outcome for the events red spots on front and back of his body and some on both legs and extreme itching, hundreds of itchy spots were resolving. No follow-up attempts are needed. No further information is expected.

Other Meds: OMEPRAZOLE; METFORMIN; LISINOPRIL; TAMSULOSIN

Current Illness:

ID: 1652285
Sex: F
Age:
State: WA

Vax Date: 05/21/2021
Onset Date: 05/21/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: unknown
Dose Series: UNK
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: Felt very sick for almost 48 hours; Whole left side of the body was numb for about a day; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0186), via an unspecified route of administration in the left arm on 21May2021 at 15:00 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. Other medical history was reported as none. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medications within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 21May2021 at 16:00, the patient felt very sick for almost 48 hours and the whole left side of the patient's body was numb for about a day. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events felt very sick for almost 48 hours and the whole left side of the patient's body was numb for about a day was recovered on an unknown date in May2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1652286
Sex: F
Age:
State:

Vax Date: 05/22/2021
Onset Date: 05/23/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Muscle sourness; lethargy; This is a spontaneous report from a non-contactable consumer, the patient. A 45-year-old non-pregnant female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the right arm on 22May2021 at 09:30 (at the age of 45-year-old) as a single dose for COVID-19 immunisation. The patient's medical history included COVID-19. Prior to vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. On 23May2021, the day after vaccination, the patient experienced muscle sourness and lethargy. The adverse events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcomes of the events muscle sourness and lethargy were resolved in May2021. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1652287
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: FLUC4
Manufacturer: SEQIRUS, INC.
Vax Name: INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT)
Lot: 276563
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: heart racing; patient may miss second dose of vaccine; This is a spontaneous report received from a contactable consumer. This consumer (patient's mother) reported for female patient that: A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: Unknown), via an unspecified route of administration on an unspecified date as dose 1, single for COVID-19 immunisation. Medical history included anxiety from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. The patient had allergic to shellfish, amoxicillin and nuts. It was reported that the caller refuses to give demographic information on herself or daughter. Caller was called on behalf of daughter. Caller daughter received first dose of vaccine in vaccination site. Caller would like to know if her daughter can get second dose of vaccine in name. Caller reports that her daughter has anxiety, allergies to shellfish, amoxicillin, nuts, and would like to know if her daughter anxiety could get worse after second dose. Caller reports that her daughter's heart was racing after first dose of vaccine. Caller would like to know if there are nuts and shellfish in vaccine. Caller reports that she heard on the news reports of heart inflammation or infection after someone gets the vaccine and would like to know more information about that. Caller would like to know how you would know if you are immunocompromised or what does that term mean. Caller would like to know how a person would know if they are allergic to ingredients in vaccine. Caller states that she heard that you could possibly get vaccine after 6 weeks. Caller requested more information on this. Caller was called because she was concerned about this vaccine, and she has some paperwork that she pulled up and has questions. Caller confirms she was called about the Pfizer COVID-19 Vaccine. Caller added, first of all, if somebody has the first vaccine and does it somewhere else can they do it. Caller clarified and asked can the second dose of the Pfizer COVID-19 vaccine be received if the first dose was given at a different location (patient may miss second dose of vaccine). Caller states she does not want to provide any additional details at this time regarding her or her daughter. Caller states she just has questions. The outcome of the events was unknown. Information on Lot/Batch number has been requested. Follow-up attempts not completed; information about lot/batch number cannot be obtained. No further information expected.

Other Meds:

Current Illness:

ID: 1652288
Sex: F
Age:
State:

Vax Date: 05/21/2021
Onset Date: 05/24/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: Swollen left armpit; Feeling of tenderness and pain; Feeling of tenderness and pain; This is a spontaneous report from a non-contactable consumer, the patient. A 33-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0177) via an unspecified route of administration in the left arm on 21May2021 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 24May2021, the patient had swollen left armpit, it was more the feeling of tenderness and pain, not "that" swollen. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events swollen left armpit and feeling of tenderness and pain was unknown at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1652289
Sex: F
Age:
State: FL

Vax Date: 03/29/2021
Onset Date: 03/29/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: Continuous severe pain in arm; Severe pain in shoulder; Joint mobility restriction; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204) via an unspecified route of administration in the left arm on 29Mar2021 at 11:00 (at the age of 64-years-old) as a single dose for COVID-19 immunisation. Medical history and Concomitant medications were not reported. The patient had known allergies. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6203) via an unspecified route of administration in the right arm on 08Mar2021 at 10:45 (at the age of 64-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 29Mar2021, the patient experienced continuous severe pain in arm, severe pain in shoulder and joint mobility restriction. The events resulted in emergency room/department or urgent care visit. Therapeutic measures were taken as a result of events and included treatment with unspecified medication (shot). The clinical outcome of the event continuous severe pain in arm, severe pain in shoulder and joint mobility restriction was not resolved. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1652290
Sex: M
Age:
State: MA

Vax Date: 04/05/2021
Onset Date: 04/01/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210428; Test Name: Rapid Covid test; Result Unstructured Data: Test Result:Nasal Swab, Negative

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: One painful white patch showed up on uvula; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8734) via an unspecified route of administration in the right arm on 05Apr2021 at 13:15 (at the age of 34-year-old) as a single dose and received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8735) via an unspecified route of administration in the right arm on 26Apr2021 at 13:15 (at the age of 34-year-old) as a single dose for COVID-19 immunisation. Medical history included multiple mouth ulcers and a painful white patch in the throat from 03Apr2021 at 06:00. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included fexofenadine (MANUFACTURER UNKNOWN), vitamin d not otherwise specified (NOS) (MANUFACTURER UNKNOWN), ultra nutrient multivitamin (MANUFACTURER UNKNOWN), all drugs used for an unknown indication from unknown dates. The patient previously took amoxicillin on an unknown date for unknown indication and experienced drug allergy. The patient was treated with a steroid for multiple mouth ulcers and a painful white patch in the throat which went away after two weeks in Apr2021. After the steroid treatment, on an unknown date in Apr2021, one painful white patch was showed up on the uvula. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had been tested for COVID-19. On 28Apr2021, the patient underwent a rapid COVID test and the result was negative. The clinical outcome of the event one painful white patch showed up on uvula was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: FEXOFENADINE; VITAMIN D [VITAMIN D NOS]

Current Illness:

ID: 1652291
Sex: F
Age:
State: MI

Vax Date: 05/19/2021
Onset Date: 05/24/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J201A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: Extremely heavy period; Fever; Headache; Body ache; Chills; Nausea; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0167) via an unspecified route of administration in the left arm on 19May2021 at 11:30 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. Medical history included light periods for years. Concomitant medications included alprazolam (XANAX) and zolpidem tartrate (AMBIEN); all from unknown date for unspecified indication and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0183) via an unspecified route of administration in the left arm on 28Apr2021 at 14:00 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. On 24May2021, five days after the vaccine, the patient experienced extremely heavy period after 73 days of no period and having light periods for years, fever, headache, body ache, chills and nausea. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The patient did not receive any treatment for the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events extremely heavy period, fever, headache, body ache, chills and nausea were not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: XANAX; AMBIEN

Current Illness:

ID: 1652292
Sex: F
Age:
State: MO

Vax Date: 05/15/2021
Onset Date: 05/21/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: severe muscle pain (arms, legs, back); swelling and redness at the injection site; Redness at the injection site.; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 15May2021 (at the age of 59-year-old) as a single dose for COVID-19 immunisation. Medical history was reported as none. The patient did not have any known allergies to medications, food or other products. The patient did not receive any medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. On 21May2021 at 08:00 (day 7 and 8 after the first dosage), the patient experienced severe muscle pain (arms, legs, back) and swelling and redness at the injection site. No therapeutic measures were taken. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events severe muscle pain (arms, legs, back) and swelling and redness at the injection site was recovering at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1652293
Sex: F
Age:
State:

Vax Date: 04/19/2021
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039k20a
Dose Series: 1
Vax Route: SYR
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Rash, Urticaria

Symptoms: Rash; Rash was still present and continues to provide discomfort; This is a spontaneous report from a non-contactable consumer, the patient. A non-pregnant female patient of unspecified age received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733), via an unspecified route of administration on 19Apr2021 as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in 2021, the patient experienced a rash which was still present and continued to provide discomfort. Since the vaccination, the patient had not been tested for COVID-19. The events resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of the events rash and was still present and continued to provide discomfort was not recovered at the time of report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1652294
Sex: F
Age:
State: CA

Vax Date: 05/12/2021
Onset Date: 05/13/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: Heart palpitations after the shot.; Fatigue; Headache; Nausea; This is a spontaneous report from a contactable consumer, the patient. A 73-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EW0173) via an unspecified route of administration in the right arm on 12May2021 at 12:00 (at the age of 73-year-old) as a single dose for COVID-19 immunisation. Medical history included mild heart palpitations with anxiety. The patient did not receive any other medications in two weeks of vaccine. prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. It was reported that the patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 13May2021 at 17:00 after the shot, the patient experienced heart palpitations, fatigue, headache and nausea. No therapeutic measures were taken as a result of the reported events. The events did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. The clinical outcome of the event heart palpitations, fatigue, and nausea were not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1652295
Sex: M
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20-2A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: swelling in his arm; a little headache; This is a spontaneous report from a contactable consumer or other non hcp (parent). A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection, Lot number and Expiration Date was not reported), via an unspecified route of administration on an unspecified date as dose number unknown, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced swelling in his arm and a little headache on an unspecified date. It was reported that, my family member just got the vaccine yesterday, and all he had was swelling in his arm, and a little headache. Caller enquired what are the risks of the pfizer-biontech covid-19 vaccine. The outcome of the events was unknown. Information on Lot/Batch number has been requested. Further information is expected.

Other Meds:

Current Illness:

ID: 1652296
Sex: M
Age:
State: CO

Vax Date: 05/24/2021
Onset Date: 05/25/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: Fever; loss of taste; This is a spontaneous report from a contactable consumer. A male patient of unknown age received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via intramuscular route of administration on 24May2021 as a single dose for COVID-19 immunisation. Medical history included COVID-19 on an unknown date and any other relevant medical history was reported as unknown. It was unknown if the patient had any known allergies. It was unknown if the patient had received any other medications within 2 weeks of vaccination. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 25May2021 at 07:00, the patient experienced fever and loss of taste. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. It was unknown if any therapeutic measures were taken for the events. The clinical outcome of the events fever and loss of taste were resolving at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1652297
Sex: F
Age:
State: MD

Vax Date: 04/23/2021
Onset Date: 04/26/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: very tired; Slept a lot; have a sound in my head, not ears, like an outside sound and it continues; This is a spontaneous report from a contactable consumer (patient). A 73-years-old non pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 vaccine, Solution for injection Batch/Lot number was not reported), via an unspecified route of administration, administered in left arm on 23Apr2021 10:45 (age at the vaccination 73-years-old) as DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunisation. Patient was not pregnant at time of vaccination. The patient medical history included Bulbar Polio at age of 5. No known allergies reported. The patient's concomitant medication(s) included losartan, metoprolol venlafaxine, biotin, and ascorbic acid (VIT C). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 26Apr2021, the patient noticed days later to be very tired, slept a lot and had sound in head, not ears, like an outside sound and it continued. Patient did not receive any treatment for an events. Prior to vaccination the patient was not diagnosed with Covid-19. Since the vaccination, the patient had not been tested for COVID-19. The outcome of the events was not recovered. The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.

Other Meds: LOSARTAN; METOPROLOL; VENLAFAXINE; BIOTIN; VIT C

Current Illness:

ID: 1652298
Sex: F
Age:
State:

Vax Date: 04/02/2021
Onset Date: 04/02/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: DTAPHEPBIP
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: DTAP + HEPB + IPV (PEDIARIX)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: Full-body skin pain/burning without rash; Full-body skin pain/burning without rash; This is a spontaneous report from a non-contactable consumer, the patient. A 46-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on 02Apr2021 at 11:00 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. The patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on 23Apr2021 at 11:00 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. Medical history included environmental allergies from an unknown date. The patient had known allergies to erythromycin. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included colecalciferol (VITAMIN D3) and krill oil (MANUFACTURER UNKNOWN); both taken for unknown indications from unknown dates and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02Apr2021 at 16:00, the patient experienced full-body skin pain/burning without rash. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events full-body skin pain/burning without rash was not recovered at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds: VITAMIN D3; KRILL OIL

Current Illness:

ID: 1652299
Sex: F
Age:
State:

Vax Date: 05/24/2021
Onset Date: 05/24/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: HIBV
Manufacturer: MERCK & CO. INC.
Vax Name: HIB (PEDVAXHIB)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: "Stomach cramps. Not severe enough to cause bad pain, but severe enough to keep me from eating more than a bite here and there".; This is a spontaneous report received from a contactable consumer, the patient. A 32-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0182) via an unspecified route of administration in the right arm on 24May2021 at 08:15(at the age of 32-years-old) as a single dose for COVID-19 immunisation. The patient had no allergies to food, medications or other products. Concomitant medications included norethisterone acetate, ethinylestradiol (AUROVELA) for unspecified indication from an unknown start date. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to COVID vaccine. The patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0167) via an unspecified route of administration in the left arm on an unknown date in 2021 as a single dose for COVID-19 immunisation. On 24May2021 at 13:00, the patient reported that she had stomach cramps not severe enough to cause bad pain, but severe enough to keep her from eating more than a bite here and there. The patient did not receive any treatment for the adverse event. The event did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. The clinical outcome of the event stomach cramps not severe enough to cause bad pain, but severe enough to keep her from eating more than a bite here and there was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: ETHINYLESTRADIOL;NORETHISTERONE ACETATE

Current Illness:

ID: 1652300
Sex: F
Age:
State:

Vax Date: 05/20/2021
Onset Date: 05/20/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: PNC13
Manufacturer: PFIZER\WYETH
Vax Name: PNEUMO (PREVNAR13)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: Multiple days of bad headache; fatigue; "foggy brain"; muscle aches; muscle aches and weakness; diarrhea; potential menstrual period change; This is a spontaneous report from a contactable consumer, the patient. A 15-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EW0176) via an unspecified route of administration in the right arm on 20May2021 at 19:30 (at the age of 15-year-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient did not receive any other medications in two weeks of vaccine. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 20May2021, the patient experienced multiple days of bad headache, fatigue, foggy brain, muscle aches and weakness, diarrhea and potential menstrual period change. No therapeutic measures were taken as a result of the reported events. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events multiple days of bad headache, fatigue, foggy brain, muscle aches and weakness, diarrhea, and potential menstrual period change were not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1652301
Sex: F
Age:
State: CA

Vax Date: 05/14/2021
Onset Date: 05/14/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: RV1
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: ROTAVIRUS (ROTARIX)
Lot:
Dose Series: 1
Vax Route: PO
Vax Site: MO

Lab Data:

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: Insomnia; Wide awake in the middle of the night; This is a spontaneous report from a contactable consumer, the patient. A 27-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the left arm on 14May2021 09:15 (at the age of 27-year-old) as a single dose for COVID-19 immunization. Medical history included no other health issues. Patient had no known allergies. The patient did not receive any medication within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the left arm on 23Apr2021 (at the age of 27-year-old) as a single dose for COVID-19 immunization. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14May2021 at 23:00, the patient had insomnia which was really frustrating. She would be wide awake in the middle of the night and it had been 10 days already. The patient never ever had issues sleeping and she experienced this only after taking 2nd shot. The events result in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken and included treatment with melatonin 1mg (MANUFACTURER UNKNOWN) medication which didn't help much in falling asleep. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event insomnia and will be wide awake in the middle of the night was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1652302
Sex: F
Age:
State: TX

Vax Date: 05/02/2021
Onset Date: 05/04/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: Eh9899
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: Skin under and around Both EYEsred, itching, swollen/Puffy; Skin under and around Both EYEsred, itching; Skin under and around Both EYEsred, itching, swollen, burning; Skin under and around Both EYEsred, itching, swollen, burning, puffy,inflamed; Skin under and around Both EYEsred, itching, swollen, burning, puffy,inflamed and irritated; Skin under and around Both EYEs red; This is a spontaneous report from a contactable consumer, the patient. A 35-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0172) via an unspecified route of administration in the left arm on 02May2021 at 12:00 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. Medical history included none. The patient had no known allergies. The patient did not receive any medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 04May2021 at 00:00, the patient experienced skin under and around both eyes red, itching, swollen, burning, puffy, inflamed and irritated. The event resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of the events and included treatment with Eyedrops and hydrocortisone. The clinical outcome of the events skin under and around both eyes red, itching, swollen, burning, puffy, inflamed, and irritated was not recovered. Patient also received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0183) via an unspecified route of administration in the left arm on 23May2021 at 12:00 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1652303
Sex: F
Age:
State: CT

Vax Date: 05/04/2021
Onset Date: 05/12/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Unevaluable event

Symptoms: Menstrual period lasting in excess of two weeks, and counting.; Hidridenitis supperativa flared up the day after vaccine.; Hidridenitis supperativa flared up the day after vaccine.; This is a spontaneous report from a contactable consumer (patient). A 42-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in Arm Left on 04May2021 09:15 (Batch/Lot number was not reported) as DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunisation. Medical history included hidridenitis supprativa. On 12May2021, the patient experienced Menstrual period lasting in excess of two weeks, and counting and Hidridenitis supperativa flared up the day after vaccine. Injection of cortisone to hidridenitis cyst Therapeutic measures were taken as a result of the events. The outcome of the events was not recovered. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1652304
Sex: F
Age:
State: VA

Vax Date: 05/20/2021
Onset Date: 05/20/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: Injection site pain,; Tiredness; Headache; Muscle pain; Chills; Fever; Nausea; Feeling unwell; Arm pain; This is a spontaneous report from a contactable consumer, the patient. A 75-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0176) via an unspecified route of administration in the left arm on 20May2021 at 12:30 (at the age of 75-years-old) as a single dose for COVID-19 immunisation. Medical history included hypertensive, hypercholesterolemia, sleep apnea, cervical pap smear abnormal, allergy to pineapple and COVID-19. Patient received unspecified other medications within two weeks of vaccination. The patient previously took morphine (MANUFACTURER UNKNOWN), unysen and experienced drug allergy. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Since the vaccination, the patient had not been tested for COVID-19. On 20May2021, the patient experienced injection site pain, tiredness, headache, muscle pain, chills, fever, nausea, feeling unwell, arm pain. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken for the adverse events. The clinical outcome of the events injection site pain, tiredness, headache, muscle pain, chills, fever, nausea, feeling unwell, arm pain were resolved on an unknown date in 2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1652305
Sex: M
Age:
State: OH

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011L20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 2021; Test Name: Heart rate; Result Unstructured Data: Test Result:15-20 BPM; Comments: 15-20BPM higher than normal.

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: elevated heart rate; During one event I had to stop the workout to catch my breath; This is a spontaneous report from a contactable consumer (reported for self). A 41-years-old male patient received second dose of BNT162B2 ((COMIRNATY); Formulation: Solution for injection; Lot/Batch number: Not reported), via an unspecified route of administration on an unspecified date in 2021 (at the of 41-years-old) as dose 2, single for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient had earlier received first dose of BNT162B2 ((COMIRNATY); Formulation: Solution for injection; Lot number: EN6204), via an unspecified route of administration in the Left arm on 08Apr2021 12:00 as dose 1, single for COVID-19 immunization and experienced elevated heart rate and Dyspnoea. Prior to vaccination, the patient was not diagnosed with COVID-19. Known allergies and other medical history were none. On an unspecified date in 2021 the patient noticed elevated heart rate when he worked out. The patient's iwatch tracked 15-20BPM higher than normal (I do the exact same workout almost everyday) for 48 hours after both doses. During one event he had to stop the workout to catch his breath (reported as "During one event I had to stop the workout to catch my breath"). Given some of the reporting of heart inflammation patient thought this would be helpful. Since the vaccination, the patient has not been tested for COVID-19. The lab data includes: Heart rate 15-20BPM higher than normal on an unspecified date in 2021. Patient received no treatment for the adverse events. The events were assessed as non serious. The outcome of events was reported as recovered on unknown date. Device Date : 25May2021 Follow-up attempts are completed. No further information is expected.

Other Meds:

Current Illness:

ID: 1652306
Sex: F
Age:
State: OH

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data: Test Name: Heart rate; Result Unstructured Data: Test Result:elevated; Comments: 15-20 BPM higher than normal

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: Noticed elevated heart rate when I worked out for 48 hours after both doses; During one event I had to stop the workout to catch my breath; This is a spontaneous report from a contactable consumer (patient husband) or other non-healthcare professional. A female patient of an unspecified age received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot number and expiration dates were not reported) dose 2 via an unspecified route of administration on an unspecified date as single dose and dose 1 of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot number: EN6204 and expiration dates were not reported) dose 1 via an unspecified route of administration in arm left on 08Apr2021 at 12:00 as single dose COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Patient had not taken any vaccination in four weeks duration neither any other medications prior to two weeks of vaccination. Patient did not have COVID-19 prior to vaccine and neither tested for COVID-19 post vaccination. It was reported that the patient had noticed elevated heart rate when she worked out. Her watch tracked 15- 20BPM (beats per minute) higher than normal (she does the exact same workout almost everyday) for 48 hours after both doses. During one event patient had to stop the workout to catch her breath. Given some of the reporting of heart inflammation reporter thought this would be helpful. Reporter wife had the exact same reaction. The patient underwent lab test procedure include Heart rate results elevated 15-20 BPM higher than normal. The events were reported as non-serious. No treatment was taken as a result of events. The outcome of all the events were reported as recovered on unknown date. Follow-Up (01Jul2021): Follow-up attempts are completed. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021598382 same reporter/AE/SD, different patients.

Other Meds:

Current Illness:

ID: 1652307
Sex: U
Age:
State:

Vax Date: 05/24/2021
Onset Date: 05/24/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data: Test Name: Body temperature; Result Unstructured Data: Test Result:101.9; Test Name: Body temperature; Result Unstructured Data: Test Result:100.7

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: Fever; Sick all the night; I was off balance; Feeling unwell; Headache; Tired; This is a spontaneous report from a contactable consumer or other non hcp. A patient of unspecified age and gender received second dose of BNT162B2 (Formulation: Solution for injection; Batch/Lot number was not reported), dose 2 via an unspecified route of administration on 24May2021 08:00 as DOSE 2, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient previously received first dose of BNT162B2 on an unspecified date for covid-19 immunisation. On 24May2021 18:00 consumer stated, I don't know if I'm directed to the correct person. Yesterday, I took my second shot of Covid19 Pfizer vaccine. I took at 8 in the morning and at 6, I started feeling unwell, I start having headache, I was off balance, I may be tired. At around 9, so it starts happening with me, high fever, I'm so tired and sick all the night. I took Tylenol at 8 and Advil at 12. The temperature is between 101.9 and it doesn't go down it was like 100.7 and I'm not feeling well. The patient received treatment with Tylenol and Advil. The patient underwent lab tests and procedures which included body temperature: 101.9 on an unspecified date, body temperature: 100.7 on an unspecified date. The outcome of the event was unknown. Information about lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1652308
Sex: F
Age:
State: NJ

Vax Date: 05/12/2021
Onset Date: 05/12/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: Severe arm pain night after shot arm was unable to move/ moderate/mild pain in the upperarm; This is a spontaneous report from a non-contactable consumer, the patient. A 42-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0173 8/21) via an unspecified route of administration in the arm left on 12May2021 at 16:00(at the age of 42-year-old) as a single dose for COVID-19 immunisation. Medical history included celiac disease from unknown date and unknown if ongoing. Concomitant medications included only vitamins/supplements (MANUFACTURER UNKNOWN) from unknown date for unspecified indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 12May2021 the patient experienced severe arm pain night after shot, all night long her whole arm was unable to move. This strong pain subsided in about 2 days. Now 2 weeks later, she still have moderate/mild pain in the upper arm. The patient did not receive any treatment for the event. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event severe arm pain night after shot arm was unable to move was recovering. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1652309
Sex: F
Age:
State: CA

Vax Date: 05/04/2021
Onset Date: 05/04/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: shortness of breath for 9days; Felt strange in my head for 2 days; Diarrhea; Flush; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 173), via an unspecified route of administration in the left arm on 04May2021 at 11:45 (at the age of 60-year-old), as a single dose for COVID-19 immunisation. Medical history included asthma, migraine and high cholesterol. The patient had a history of allergy to iodine dye. Concomitant medications included vitamins (MANUFACTURER UNKNOWN) and herbal supplements (MANUFACTURER UNKNOWN) from an unknown date for an unknown indication. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 04May2021, the patient experienced 3 very powerful weird sensations like a flush, shortness of breath for 9 days, diarrhea, the flush feeling had made the patient bend in half and take mask off and felt strange in head for 2 days. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events a flush, shortness of breath for 9 days, diarrhea and felt strange in head for 2 days were recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1652310
Sex: F
Age:
State: NJ

Vax Date: 05/18/2021
Onset Date: 05/21/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Swollen lymph nodes in neck on side of shot; tiredness; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0177), via an unspecified route of administration on 18May2021 at 14:30 (at the age of 56-year-old), as a single dose for COVID-19 immunisation. Medical history was not reported and the patient did not have a history of allergies to any food or medications or other products. Concomitant medications included valsartan (MANUFACTURER UNKNOWN) and rosuvastatin (MANUFACTURER UNKNOWN) for an unknown indication from an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 21May2021, the patient experienced swollen lymph nodes in neck on side of shot and tiredness. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event swollen lymph nodes in neck on side of shot and tiredness was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: VALSARTAN; ROSUVASTATIN

Current Illness:

ID: 1652311
Sex: F
Age:
State: NE

Vax Date: 05/20/2021
Onset Date: 05/20/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Nausea

Symptoms: Throat swelled; Had a very hard time breathing; She had a barking cough and couldn't stop; She was dizzy; Had a hard time standing; This is a spontaneous report from a contactable healthcare professional. A 40-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0164) via an unspecified route of administration in the left leg on 20May2021 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. Medical history included mast cell activation syndrome. The patient had known allergies with gelatine, egg and other allergy (unspecified allergy). The patient did not receive any concomitant medication. It was unknown whether prior to the vaccination, the patient was diagnosed with COVID-19. It was unknown whether since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 20May2021, the patient experienced throat swelled, had a very hard time breathing, she had a barking cough and couldn't stop, she was dizzy and had a hard time standing. The events resulted in emergency room/department or urgent care. It was unknown whether any therapeutic measures were taken as a result of the events. The clinical outcome of the events throat swelled, had a very hard time breathing, she had a barking cough and couldn't stop. She was dizzy and had a hard time standing was unknown at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1652312
Sex: F
Age:
State: IL

Vax Date: 05/24/2021
Onset Date: 05/25/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain

Symptoms: Very painful axillary (left) lymph node; Swollen axillary (left) lymph node; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0173) via an unspecified route of administration in the left arm on 24May2021 at 10:00 (at the age of 36-year-old) as a single dose for COVID-19 immunisation. No relevant medical history was reported. The patient did not have allergies to medications, food, or other products. Concomitant medication was not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0172) via an unspecified route of administration in the left arm on 03May2021 at 10:00 (at the age of 36-year-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 25May2021 at 01:00, the patient experienced very painful and swollen axillary (left) lymph node. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the adverse event. The clinical outcome of the event very painful and swollen axillary (left) lymph node was unknown at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1652313
Sex: F
Age:
State: PA

Vax Date: 03/01/2021
Onset Date: 03/01/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210421; Test Name: PCR; Test Result: Negative

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Sharp R Breast pain (opposite side of where shot was given); Pins and needle-like pain at nipple and entire breast.; This is a spontaneous report from a contactable nurse, the patient. A 50-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EN6203) via an unspecified route of administration in the left arm on 01Mar2021 at 08:00 (at the age of 50-year-old) as a single dose for COVID-19 immunisation. Medical history included hypertension (HTN) and poly cystic ovarian syndrome (PCOS). Concomitant medications included metformin (MANUFACTURER UNKNOWN), metoprolol (MANUFACTURER UNKNOWN), lisinopril (MANUFACTURER UNKNOWN) and dulaglutide (TRULICITY) all started from an unknown date for unspecified indication and unknown if ongoing. The patient had no known allergies. Prior to the vaccination, the patient was not tested positive for COVID-19. On 01Mar2021 at 23:45, the patient experienced sharp R breast pain (opposite side of where shot was given) and pins and needle-like pain at nipple and entire breast. No therapeutic measures were taken as a result of the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had been tested for COVID-19. The patient underwent a lab test on 21Apr2021 which included the polymerase chain reaction (PCR) test and the result was found to be negative. The clinical outcome of the events sharp R breast pain (opposite side of where shot was given) and pins and needle-like pain at nipple and entire breast was recovered on 08Mar2021, seven days post the second injection date. No follow-up attempts are needed. No further information is expected.

Other Meds: METFORMIN; METOPROLOL; LISINOPRIL; TRULICITY

Current Illness:

ID: 1652314
Sex: F
Age:
State:

Vax Date: 05/14/2021
Onset Date: 05/18/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011j20a
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: Joint pains -fingers, toes, left elbow, knees; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EW0186) via an unspecified route of administration in the left arm on 14May2021 as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EW0171) via an unspecified route of administration in the left arm on 23Apr2021 as a single dose for COVID-19 immunisation. On 18May2021 the patient experienced joint pains -fingers, toes, left elbow and knees. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. The clinical outcome of the event joint pains -fingers, toes, left elbow and knees was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1652315
Sex: F
Age:
State:

Vax Date: 05/20/2021
Onset Date: 05/22/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Tremor

Symptoms: Lymph node under left ear swelled and remains swollen as of 5/25.; This is a spontaneous report from a non-contactable consumer, the patient. A 67-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN0187) via an unspecified route of administration in the right arm on 20May2021 at 15:15 (at the age of 67-years-old) as a single dose for COVID-19 immunisation. Medical history included mitral valve prolapse and cholesterol high. The patient had no known allergies. Concomitant medications included pravastatin (MANUFACTURER UNKNOWN); ezetimibe (ZETIA) and apixaban (ELIQUIS) from an unknown date, for unknown indications and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 22May2021, the patient experienced lymph node under left ear swelled. The patient reported that she had lymph node under left ear swelled within 48 hours of vaccination and remained swollen as of 25May2021. No therapeutic measures were taken as a result of the event. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the event lymph node under left ear swelled was not recovered at the time of report. No follow-up attempts are possible. No further information is expected.

Other Meds: PRAVASTATIN; ZETIA; ELIQUIS

Current Illness:

ID: 1652316
Sex: F
Age:
State: NH

Vax Date: 01/07/2021
Onset Date: 05/10/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: ALT increased; AST increased; Vertigo; This is a spontaneous report from a contactable healthcare professional, the patient. A 58-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 07Jan2021 (at the age of 58-year-old) as a single dose for COVID-19 immunisation. Medical history included Megoblastic Macrocytic Anemia. Concomitant medications was not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EH9899) via an unspecified route of administration in the arm left on 16Dec2020 (at the age of 58-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 10May2021, 4 months later, patient had elevated liver enzymes ALT and AST. Patient had no known history and did not drink not obese, never elevated. Also the patient dealing with horrible vertigo. She spoke to 3 other people she know 2 in the same department that have the same thing going on and she was questioning whether it is a possible side effect? The event resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of the event ALT increased, AST increased and vertigo were not resolved at the time of this report. No follow-up attempts are needed; information about lot/batch number can not be obtained.

Other Meds:

Current Illness:

ID: 1652317
Sex: F
Age:
State: WA

Vax Date: 05/09/2021
Onset Date: 05/10/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: UNK
Manufacturer: UNKNOWN MANUFACTURER
Vax Name: VACCINE NOT SPECIFIED (NO BRAND NAME)
Lot:
Dose Series: UNK
Vax Route: SYR
Vax Site: UN

Lab Data: Test Date: 20210514; Test Name: PCR oral swab; Test Result: Negative

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: Fatigue; Dizziness; Diarrhea; Excessive gas; Nausea; Headaches; Chills; Night sweats; This is a spontaneous report from a contactable consumer, the patient. A 35-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0167) via an unspecified route of administration in the left arm on 09May2021 at 16:00 (at the age of 35-year-old) as a single dose for COVID-19 immunisation. Medical history included fibromyalgia and anxiety. The patient previously took Doxycycline and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included trazodone (MANUFACTURER UNKNOWN) and buspirone (MANUFACTURER UNKNOWN) both for unknown indications from an unknown start date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the left arm on 18Apr2021 at 16:45 (at the age of 35-year-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10May2021, for 14 days following the second dose the patient experienced fatigue, dizziness, diarrhea, excessive gas, nausea, headaches and on occasion had chills and night sweats. The events resulted in doctor or other health care professional office/clinic visit and emergency room/department or urgent care. It was unknown whether therapeutic measures were taken as a result of the events. On 14May2021, the patient underwent PCR oral swab test and the result was negative. The clinical outcome of the events fatigue, dizziness, diarrhea, excessive gas, nausea, chills, night sweats and headaches were recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: TRAZODONE; BUSPIRONE.

Current Illness:

ID: 1652318
Sex: F
Age:
State: MA

Vax Date: 05/16/2021
Onset Date: 05/17/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210511; Test Name: SARS-CoV-2 test; Test Result: Negative ; Comments: Post vaccination type: Nasal swab

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: Body ache; Fatigue; Chills; Sweat; missed period over a week and is still missed which is unusual for me; This is a spontaneous report from a contactable consumer, the patient. A 30-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the left arm on 16May2021 at 14:00 (at the age of 30-years-old), as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the left arm on 25Apr2021 at 14:00 (at the age of 30-years-old), as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 17May2021, the patient experienced body ache, fatigue, chills, sweat, missed period over a week and is still missed which is unusual for the patient, but all other side effect only lasted two days. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events body ache, fatigue, chills and sweat were resolved on 18May2021 and the clinical outcome of the event missed period over a week and is still missed which is unusual was not resolved at the time of reporting. Information on lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1652319
Sex: F
Age:
State: MI

Vax Date: 05/24/2021
Onset Date: 05/25/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: Swollen lymph nodes left armpit; Fatigue; Body aches; This is a spontaneous report from a contactable consumer, the patient. A 44-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ew0191) via an unspecified route of administration in the left arm on 24May2021 at 11:45 (at the age of 44-year-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy. The patient did not receive any medications within two weeks of vaccination. The patient previously received first dose BNT162B2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, lot number: Ew0176) in the left arm on 03May2021 at 11:45 (at the age of 44-year-old) as a single dose for COVID-19 immunisation. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 25May2021 at 10:00 the patient experienced swollen lymph nodes left armpit, fatigue and body aches. No therapeutic measures were taken as a result of the events. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19The clinical outcome of the event swollen lymph nodes left armpit, fatigue and body aches was unknown. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1652320
Sex: F
Age:
State: OK

Vax Date: 05/10/2021
Onset Date: 05/12/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: High pitched tinnitus mostly affects left ear; left atypical/tonic pupil; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the left arm on 10May2021 at 10:00 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. Medical history of the patient was not available. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the left arm on 08Apr2021 at 10:00 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. Concomitant medications included cetirizine hydrochloride (ZYRTEC) for unspecified indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 12May2021 at 10:00, the patient experienced high pitched tinnitus mostly affects left ear and left atypical/tonic pupil. The events resulted in doctor or other healthcare professional office/clinic visit. The patient did not receive any treatment for the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events high pitched tinnitus mostly affects left ear and left atypical/tonic pupil were not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: ZYRTEC [CETIRIZINE HYDROCHLORIDE]

Current Illness:

ID: 1652321
Sex: F
Age:
State: WA

Vax Date: 05/24/2021
Onset Date: 05/25/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EK9231
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: Fatigue; soreness in left arm; soreness in shoulder; soreness in ribs; Body aches; headache; Trouble sleeping; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: ew0187) via an unspecified route of administration in the left arm on 24May2021 at 09:00 (at the age of 36-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient was allergic to bay shrimp. Concomitant medications included fluoxetine (MANUFACTURER UNKNOWN), gabapentin (MANUFACTURER UNKNOWN), bupropion (MANUFACTURER UNKNOWN) and famotidine (MANUFACTURER UNKNOWN); all from an unknown date, for an unknown indication, unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: er8736) via an unspecified route of administration in the left arm on 03May2021 at 09:00 (at the age of 36-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 25May2021, the patient experienced fatigue, soreness in left arm, shoulders and ribs, body aches, headache and trouble sleeping. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events fatigue, soreness in left arm, shoulders and ribs, body aches, headache and trouble sleeping were recovered on 25May2021. No follow-up attempts are needed. No further information is expected.

Other Meds: FLUOXETINE; GABAPENTIN; BUPROPION; FAMOTIDINE

Current Illness:

ID: 1652322
Sex: F
Age:
State: GA

Vax Date: 05/24/2021
Onset Date: 05/25/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210525; Test Name: Body temperature; Result Unstructured Data: Test Result:102 Units:{DF}; Comments: 102 fever by Tuesday at 6pm

Allergies:

Symptom List: Pain in extremity

Symptoms: 102 fever by Tuesday at 6pm. body chest, chills, my arm hurt feel my back into my fingers.; body chest, chills, my arm hurt feel my back into my fingers.; body chest, chills, my arm hurt feel my back into my fingers.; body chest, chills, my arm hurt feel my back into my fingers.; body chest, chills, my arm hurt feel my back into my fingers.; body chest, chills, my arm hurt feel my back into my fingers.; The joints of my fingers hurt.; My lymph node in my arm pit is swollen so much I can't lift my arm; My lymph node in my arm pit is swollen so much I can't lift my arm.; The left side of my breast feels like I've been punched.; There's a large knot and heat at the injection site.; There's a large knot and heat at the injection site.; I went to bed Tuesday at 4pm and couldn't get out of bed until Wednesday at 9am.; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Er8734) via an unspecified route of administration in the left arm on 24May2021 at 18:30 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. The patient had no known allergies to medications, food, or other products. The patient received other medication within two weeks of vaccination which included Probiotics. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient experienced 102 (unspecified units) fever by Tuesday, on 25May2021 at 16:00. Body chest, chills, the patients arm hurt felt her back into her fingers. The joints of her fingers hurt. The patients lymph node in her arm pit was swollen so much that she couldn't lift her arm. The patient went to bed Tuesday 25May2021, at 16:00 and couldn't get out of bed until Wednesday, 26May2021 at 09:00. The left side of her breast felt like she had been punched. There was a large knot and heat at the injection site. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the event. The clinical outcome of the events 102 (unspecified units) fever, body chest, chills, arm hurt felt her back into her fingers, the joints of fingers hurt, lymph node in arm pit was swollen so much that she couldn't lift her arm, couldn't get out of bed until Wednesday, 26May2021 at 09:00, the left side of her breast felt like she had been punched, a large knot and heat at the injection site was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1652323
Sex: F
Age:
State: NY

Vax Date: 05/21/2021
Onset Date: 05/21/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 2
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: Chills; Cold; Weak; lightheaded; Nausea; Vomited; Slight dizzy spell; Feeling pain under armpit; Swelling in arm/armpit; feeling pain on arm; Feeling tired; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0186) via an unspecified route of administration in the arm left on 21May2021 at 13:30 (at the age of 50-year-old) as a single dose for COVID-19 immunisation. Medical history included uterine fibroids, breast cyst (not being treated) and indigestion (can not digest raw vegetables and banana). Concomitant medications included 310 nutrition meal replacement protein powder (MANUFACTURER UNKNOWN). The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0175) via an unspecified route of administration in the arm left on 30Apr2021 at 13:30 (at the age of 50-year-old) as a single dose for COVID-19 immunisation. It was unknown whether the patient was diagnosed with COVID-19, prior to the vaccination. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 21May2021, after second dose patient felt ok but then in the evening, began feeling pain and swelling on arm and began feeling tired too. On 22May2021, Saturday night patient began feeling pain and swelling under armpit. On 23May2021 at 00:30, the following day on Sunday had a slight dizzy spell. On 24May2021 Monday, patient would not up dizzy with cold chills, weak and lightheaded with nausea, also vomited the water drank after patient woke up. This lasted all day and patient recovering and feeling somewhat better from everything at the time of this report. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of these events. The clinical outcome of the event swelling in arm/armpit, feeling tired, feeling pain on arm, feeling pain under armpit, slight dizzy spell, chills, cold, weak, lightheaded, nausea and vomited was recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1652324
Sex: F
Age:
State: OH

Vax Date: 05/03/2021
Onset Date: 05/03/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: Headache; left face numbness; left eye pain; fatigue; BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose and dose 2 on 03May2021.; BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose and dose 2 on 03May2021.; This is a spontaneous report from a contactable consumer (patient). This 20-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), dose 1 via an unspecified route of administration, administered in Arm Right on 03May2021 12:30 (Batch/Lot Number: Er8736, Age at vaccination: 20 years) as dose 1, single and dose 2 via an unspecified route of administration, administered in Arm Right on 03May2021 (Batch/Lot Number: Ew0172) as dose 2, single for COVID-19 immunisation. The patient was not pregnant at the time of vaccination. The patient medical history was not reported. There were no concomitant medications. The patient previously took benzathine benzylpenicillin (TERBOCYL) and experienced allergies. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not receive any other medications within 2 weeks of vaccination. Prior to vaccination, was the patient not diagnosed with COVID-19. Since the vaccination, has the patient not been tested for COVID-19. On 20May2021, the patient experienced headache, numbness of the left side of the face, left eye pain, fatigue. The patient did not receive treatment for the events "headache, numbness of the left side of the face, left eye pain, fatigue". The outcome of the events "Headache, numbness of the left side of the face, left eye pain, fatigue" was not recovered whereas for other events it was unknown. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1652325
Sex: M
Age:
State: VA

Vax Date: 05/23/2021
Onset Date: 05/23/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: Injection site pain; Tiredness; Headache; Joint pain; Fever; Nausea; Feeling unwell; Vomiting; This is a spontaneous report from a contactable consumer, the patient. A 17-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0168) via an unspecified route of administration in the left arm on 23May2021 at 14:30 (at the age of 17-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient previously took penicillin (MANUFACTURER UNKNOWN), and amoxicillin (MANUFACTURER UNKNOWN); both from an unknown date to an unknown date for an unknown indication and experienced allergy. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0173) via an unspecified route of administration in the left arm on 02May2021 at 02:30 (at the age of 17-year-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 23May2021 at 02:45 the patient experienced injection site pain, tiredness, headache, joint pain, fever, nausea, feeling unwell, and vomiting. All symptoms were lasting for 3-4 days. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the adverse events. The clinical outcome of the events injection site pain, tiredness, headache, joint pain, fever, nausea, feeling unwell, and vomiting were recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1652326
Sex: F
Age:
State: MN

Vax Date: 05/20/2021
Onset Date: 05/01/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 026LZOA
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Vomiting

Symptoms: have had a headache varying from mild to severe since day 2 of the 2nd dose.; Last menstruation was on 4/27. should have started menstruation on 5/22. still have not menstruated as of 5/26.; Exhaustion has impacted my daily life since the night of the 2nd dose.; have been sleeping between 12-18 hours per day since the 2nd dose.; Injection site got progressively more itchy, red, and swollen from day 1-6 of the 2nd dose.; Injection site got progressively more itchy, red, and swollen from day 1-6 of the 2nd dose.; Injection site got progressively more itchy, red, and swollen; Days 1-2 of the 2nd dose of vaccination experienced fever; Days 1-2 of the 2nd dose of vaccination experienced fever, dizziness; Days 1-2 of the 2nd dose of vaccination experienced fever, dizziness, and was out of breath easily.; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EWG177) via an unspecified route of administration in the arm left on 20May2021 at 12:45 (at the age of 37-year-old) as a single dose for COVID-19 immunisation. Medical history included asthma, spinal cord problems from an injury on unknown dates. Concomitant medications were not reported. The patient had severe reaction for IV (intravenous) dyes for testing. The patient previously took erythromycin and had sensitivity towards it. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EWO167) via an unspecified route of administration in the arm left on 29Apr2021 at 12:45 as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination the patient had not been tested positive for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On20May021 at 20:00, it was reported that the patient last menstruation was on 27Apr2021 and she should have started menstruation on 22May2021 however she still had not menstruated as of 26May2021. The patient had only been sexually active with her husband who had a vasectomy 10 years ago and recently tested with 0 sperm count. On an unknown date of May2021, days 1-2 of the 2nd dose of vaccination she experienced fever, dizziness and was out of breath easily. On 22May2021, the patient had a headache varying from mild to severe since day 2 of the 2nd dose. Only on date 24May2021 was severe enough to medicate with Acetaminophen, Naproxen, and Caffeine. On 20May2021, injection site got progressively more itchy, red, and swollen from day 1-6 of the 2nd dose. The effects were similar to when patient would have allergic reactions to bug bites as a child. That day was the first day when the patient noticed improvement, and the effects of the injection site were barely noticeable. On 20May2021 at 20:00, exhaustion had impacted the patient daily life since the night of the 2nd dose. She had been sleeping between 12-18 hours per day since the 2nd dose. Therapeutic measures were taken as a result of the event headache which included treatment with Acetaminophen, Naproxen, Caffeine, Tylenol and Aleve and for the event fever which included treatment with Tylenol. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events she should have started menstruation on 22May2021 however she still had not menstruated as of 26May2021; fever, dizziness and was out of breath easily; headache; injection site got progressively more itchy, red, and swollen from day 1-6 of the 2nd dose; was resolving while that of the events exhaustion and she had been sleeping between 12-18 hours per day since the 2nd dose was not resolved at the time of the report.

Other Meds:

Current Illness:

ID: 1652327
Sex: F
Age:
State: PR

Vax Date: 05/19/2021
Onset Date: 05/20/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: fever; muscle pain; bone pain; chills; She might have infected of COVID-19; This is a spontaneous report from a contactable consumer (patient) via medical information team. A 70-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EW0186), dose 1 via an unspecified route of administration on 19May2021 (at the age of 70-year-old) as a single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. She was vaccinated on 19May2021 and next day on 20May2021 she experienced fever, muscle pain, bone pain, chills and basically all the symptoms described on information she was provided with. All symptoms persist after a week of vaccination except for the fever. She might have infected of COVID-19 and not knowing since she has all symptoms. Outcome of event fever was recovered in May2021, for COVID-19 was unknown, for other events was not recovered. Follow-up attempts completed. No further information expected.

Other Meds:

Current Illness:

ID: 1652328
Sex: F
Age:
State: PA

Vax Date: 04/01/2021
Onset Date: 04/02/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: severe inflammatory response, specifically in R knee; severe inflammatory response, specifically in R knee. Largely swollen, severe pain, unable to bend; Woke up after second dose with severe inflammatory response, specifically in R knee. Largely swollen, severe pain, unable to bend; Woke up after second dose with severe inflammatory response, specifically in R knee. Largely swollen, severe pain, unable to bend; This is a spontaneous report from a contactable consumer. A non-pregnant 31 year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 2 via an unspecified route of administration, administered in left arm on 01Apr2021 14:00 (Batch/Lot Number: EP7534) as dose 2, single for COVID-19 immunisation. Medical history included covid-19 from an unknown date and unknown if ongoing. There were no concomitant medications. The patient previously took BNT162B2 dose 1 on 12Mar2021 for covid-19 immunisation, BIAXIN and experienced allergies. The patient woke up after second dose on 02Apr2021 with severe inflammatory response, specifically in R knee. Largely swollen, severe pain, unable to bend. It's been almost 2 months since second dose and have been in physical therapy for weeks trying to repair the knee. The outcome of the events was not recovered.

Other Meds:

Current Illness:

ID: 1652329
Sex: M
Age:
State: WA

Vax Date: 05/24/2021
Onset Date: 05/24/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025j20-2A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: burning or discomfort in lungs; discomfort in throat; discomfort in nose; eye discomfort; coughing; trouble breathing; trouble talking; sweating profusely; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0177) via an unspecified route of administration in the left arm on 24May2021 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. Medical history included allergy to latex. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included diphenhydramine, paracetamol, phenylpropanolamine hydrochloride (BENADRYL) and cannabidiol (MANUFACTURER UNKNOWN); both for unspecified indication and unknown start date. On 24May2021, approximately an hour after the shot, patient was driving home and suddenly experienced horrible burning/discomfort in lungs, throat, nose, and eyes. He started coughing and had trouble breathing/talking. He also started sweating profusely. He managed to drive himself to the hospital where he let the symptoms subside over the next hour. It felt like he had inhaled tear gas. He stated he never experienced anything like it before in his life. Within a few hours of the initial experience, he felt perfectly fine. Even the next day he had zero symptoms. The events resulted in doctor or other healthcare professional office/clinic visit. The patient did not receive any treatment for the events. The clinical outcome for the events chest burning/discomfort in lungs, throat discomfort, discomfort in nose, eye discomfort, coughing, trouble breathing/talking and sweating profusely were recovered on 24May2021. No follow-up attempts are needed. No further information is expected.

Other Meds: BENADRYL; CANNABIDIOL

Current Illness:

ID: 1652330
Sex: M
Age:
State: OR

Vax Date: 05/05/2021
Onset Date: 05/06/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: left foot swelled up, turned red and was painful, especially at achilles tendon; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0179) via an unspecified route of administration in the left arm on 05May2021 at 13:30 (at the age of 62-year-old) as a single dose for COVID-19 immunisation. Medical history included enlarged prostate. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient had no known allergies. Concomitant medications included tamsulosin hydrochloride (MANUFACTURER UNKNOWN) and multivitamin; all for unknown indication from unknown dates and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06May2021 at 13:00, about 24 hours after vaccination, the patient's left foot swelled up, turned red and it was painful, especially at achilles tendon. The patient could not walk with it for a few days. The swelling subsided but after 3 weeks it was still slightly swollen and red. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the event achilles tendinitis and included treatment with over-the-counter advil, 18 pills over 3 days. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event achilles tendinitis was recovered with sequelae on an unknown date in May2021. No follow-up attempts are needed. No further information is expected.

Other Meds: TAMSULOSIN HYDROCHLORIDE.

Current Illness:

ID: 1652331
Sex: F
Age:
State: VA

Vax Date: 05/12/2021
Onset Date: 05/13/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: 3 separate occasions of nose bleeds; This is a spontaneous report from a contactable consumer, the patient. A 16-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0167) via an unspecified route of administration in the left arm on 12May2021 at 17:00 (at the age of 16-year-old) as a single dose for COVID-19 immunisation. Medical history was reported as none. The patient did not have any allergies to medications, food, or other products. Concomitant medications included desogestrel, ethinylestradiol (KARIVA) from an unknown date for an unknown indication. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 13May2021 at 14:00 the patient experienced 3 separate occasions of nose bleeds the day or two following vaccination. The adverse events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the event nose bleeds was recovered on an unknown date in May2021. No follow-up attempts are needed. No further information is expected.

Other Meds: KARIVA

Current Illness:

Total 2021 VAERS Injuries: 654,986

Page last modified: 13 November 2021 9:17am